A cancer scientist and pharma veteran turned founder, Zina spent a decade in oncology drug discovery before leading Phase III trials at Parexel and AstraZeneca. Driven by a vision of a disease-free world, she founded Yendou, an AI-powered infrastructure automating clinical ops to cut drug development timelines by 40%, eliminating the gap between science and medicine.